Hisamitsu Pharmaceutical Co (FSE:4530) PE Ratio: 14.80 (As of Jun. 26, 2026) — 39% Below Median


FSE:4530 Hisamitsu Pharmaceutical Co Inc FSE:4530
89 GF Score
Price 円3,975.00
GF Value 円3,237.07
View Full Analysis

What is Hisamitsu Pharmaceutical Co PE Ratio?

Hisamitsu Pharmaceutical Co FSE:4530 89 PE Ratio is 14.80 as of Jun. 26, 2026, which is 39% below its 10-year median of 24.14. GuruFocus rates FSE:4530 with a GF Score™ of 89/100 and a GF Value™ of 円3,237.07.

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-06-26), Hisamitsu Pharmaceutical Co's share price is 円3975.00. Hisamitsu Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2025 was 円268.56. Therefore, Hisamitsu Pharmaceutical Co's PE Ratio for today is 14.80.

Good Sign:

Hisamitsu Pharmaceutical Co Inc stock PE Ratio (=14.4) is close to 10-year low of 14.28.

During the past 13 years, Hisamitsu Pharmaceutical Co's highest PE Ratio was 46.31. The lowest was 14.28. And the median was 24.14.

Hisamitsu Pharmaceutical Co's EPS (Diluted) for the three months ended in Nov. 2025 was 円68.69. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Nov. 2025 was 円268.56.

As of today (2026-06-26), Hisamitsu Pharmaceutical Co's share price is 円3975.00. Hisamitsu Pharmaceutical Co's EPS without NRI for the trailing twelve months (TTM) ended in Nov. 2025 was 円271.99. Therefore, Hisamitsu Pharmaceutical Co's PE Ratio without NRI ratio for today is 14.61.

During the past 13 years, Hisamitsu Pharmaceutical Co's highest PE Ratio without NRI was 45.37. The lowest was 14.61. And the median was 24.05.

Hisamitsu Pharmaceutical Co's EPS without NRI for the three months ended in Nov. 2025 was 円70.88. Its EPS without NRI for the trailing twelve months (TTM) ended in Nov. 2025 was 円271.99.

During the past 12 months, Hisamitsu Pharmaceutical Co's average EPS without NRI Growth Rate was 10.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was 22.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 21.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was -0.40% per year.

During the past 13 years, Hisamitsu Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 28.60% per year. The lowest was -21.70% per year. And the median was 1.70% per year.

Hisamitsu Pharmaceutical Co's EPS (Basic) for the three months ended in Nov. 2025 was 円68.77. Its EPS (Basic) for the trailing twelve months (TTM) ended in Nov. 2025 was 円268.56.

Back to Basics: PE Ratio


Hisamitsu Pharmaceutical Co  (FSE:4530) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Hisamitsu Pharmaceutical Co PE Ratio Related Terms


Hisamitsu Pharmaceutical Co PE Ratio Historical Data

* Premium members only.

The historical data trend for Hisamitsu Pharmaceutical Co's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co PE Ratio Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.75 34.35 23.23 14.26 14.80

Hisamitsu Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.26 15.82 14.75 14.40 At Loss

FSE:4530 vs ZTS: PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's PE Ratio falls into.


FSE:4530
89GF Score
Hisamitsu Pharmaceutical Co Inc FSE:4530
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hisamitsu Pharmaceutical Co PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Hisamitsu Pharmaceutical Co's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=3975.00/268.560
=14.8

Hisamitsu Pharmaceutical Co's Share Price of today is 円3975.00.
Hisamitsu Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円268.56.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 14.80 mean?
Hisamitsu Pharmaceutical Co (FSE:4530) has a PE Ratio of 14.80 as of Jun. 26, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Hisamitsu Pharmaceutical Co and its competitors. This is 39% below median its historical median of 24.14. Over the past decade, Hisamitsu Pharmaceutical Co's PE Ratio has ranged from 14.28 to 46.31.
Is Hisamitsu Pharmaceutical Co's PE Ratio too high?
Hisamitsu Pharmaceutical Co's current PE Ratio of 14.80 is 39% below median its 10-year median of 24.14. Over the past 10 years, this metric has ranged from a low of 14.28 to a high of 46.31. Overall, Hisamitsu Pharmaceutical Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Hisamitsu Pharmaceutical Co's PE Ratio compare to ZTS?
Hisamitsu Pharmaceutical Co's PE Ratio of 14.80 can be compared against companies in the Drug Manufacturers industry. Historically, Hisamitsu Pharmaceutical Co's own PE Ratio has ranged from 14.28 to 46.31 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Drug Manufacturers company?
A good PE Ratio depends on the Drug Manufacturers industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Hisamitsu Pharmaceutical Co and its competitors. Hisamitsu Pharmaceutical Co's current PE Ratio is 14.80, which is 39% below median its own 10-year median of 24.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hisamitsu Pharmaceutical Co stock overvalued right now?
Hisamitsu Pharmaceutical Co (FSE:4530) has a current PE Ratio of 14.80. The stock's GF Value™ is 円3,237.07, compared to a current price of 円3,975.00 — trading 22.8% above its estimated fair value. The current PE Ratio is 14.80, which is 39% below median its 10-year median of 24.14. Hisamitsu Pharmaceutical Co's overall GF Score™ is 89/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For Hisamitsu Pharmaceutical Co (FSE:4530), the current PE Ratio is 14.80 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hisamitsu Pharmaceutical Co (FSE:4530) Overvalued in 2026?

Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued. The current stock price of 円3,975.00 is trading 22.8% above its estimated GF Value™ of 円3,237.07.

Key valuation signals for FSE:4530:

  • PE Ratio: 14.80 (39% below median its 10-year median of 24.14)
  • GF Value™: 円3,237.07 vs. price of 円3,975.00 (22.8% above fair value)
  • GF Score™: 89/100

No single metric tells the full story. See the FSE:4530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hisamitsu Pharmaceutical Co Business Description

Other Exchanges HTSUY:USA
Address 408 Tashiro Daikancho, Saga Prefecture, Tosu, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
89GF Score

Get the complete analysis for FSE:4530

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,975.00
Price
円3,237.07
GF Value